Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144/A Apr 16, 2026
144 Apr 16, 2026
4 Apr 10, 2026 FORM 4
144 Apr 8, 2026
4 Apr 2, 2026 FORM 4
8-K Apr 2, 2026 8-K
4 Apr 1, 2026 FORM 4
4 Apr 1, 2026 FORM 4
4 Mar 30, 2026 FORM 4
SCHEDULE 13G/A Mar 27, 2026
144 Mar 26, 2026
4 Mar 24, 2026 FORM 4
4 Mar 24, 2026 FORM 4
8-K/A Mar 23, 2026 8-K/A
4 Mar 19, 2026 FORM 4
4 Mar 18, 2026 FORM 4
144 Mar 17, 2026
144 Mar 16, 2026
SCHEDULE 13G/A Mar 6, 2026
8-K Mar 3, 2026 8-K
8-K Mar 3, 2026 8-K
4 Feb 24, 2026 FORM 4
4 Feb 24, 2026 FORM 4
4 Feb 23, 2026 FORM 4
144 Feb 20, 2026
← Newer Page 5 of 40 · 995 filings Older →